Insider Transactions in Q4 2021 at Veracyte, Inc. (VCYT)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2021
|
Karin Eastham Director |
SELL
Open market or private sale
|
Direct |
5,000
-36.44%
|
$225,000
$45.0 P/Share
|
|
Dec 17
2021
|
Karin Eastham Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+26.71%
|
$60,000
$12.12 P/Share
|
|
Dec 09
2021
|
Bonnie H Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,286
+13.3%
|
$90,288
$8.86 P/Share
|
|
Dec 07
2021
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Open market or private sale
|
Direct |
6,125
-5.81%
|
$245,000
$40.62 P/Share
|
|
Dec 07
2021
|
Giulia C Kennedy Chief Scientific & Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,125
+5.43%
|
$153,125
$25.62 P/Share
|
|
Dec 06
2021
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Open market or private sale
|
Direct |
9,232
-5.69%
|
$332,352
$36.25 P/Share
|
|
Dec 06
2021
|
Giulia C Kennedy Chief Scientific & Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,156
+6.89%
|
$106,028
$13.1 P/Share
|
|
Dec 02
2021
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
912
-1.83%
|
$35,568
$39.22 P/Share
|
|
Dec 02
2021
|
Bonnie H Anderson Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,288
-3.54%
|
$89,232
$39.22 P/Share
|
|
Nov 01
2021
|
Giulia C Kennedy Chief Scientific & Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
149
-0.3%
|
$7,599
$51.8 P/Share
|
|
Nov 01
2021
|
Karin Eastham Director |
SELL
Open market or private sale
|
Indirect |
4,400
-58.33%
|
$72,028,000
$16370.74 P/Share
|